Pages that link to "Q26997330"
The following pages link to Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases (Q26997330):
Displayed 6 items.
- Effects of de-escalated bisphosphonate therapy on the Functional Assessment of Cancer Therapy-Bone Pain, Brief Pain Inventory and bone biomarkers (Q36491554) (← links)
- Burden of skeletal-related events in prostate cancer: unmet need in pain improvement (Q38255741) (← links)
- Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents (Q38297692) (← links)
- Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure. (Q38868066) (← links)
- Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome. (Q39447376) (← links)
- (Q77792389) (redirect page) (← links)